Castle Hook Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$558M Buy
+465,187
New +$475M 2.56% 4
2026
Q1
Sell
-383,550
Closed -$412M 70
2025
Q4
$412M Sell
383,550
-15,509
-4% -$14.8M 1.71% 6
2025
Q3
$304M Buy
399,059
+293,609
+278% +$218M 1.54% 12
2025
Q2
$82.2M Sell
105,450
-209,857
-67% -$163M 0.47% 32
2025
Q1
$260M Buy
315,307
+224,981
+249% +$187M 2.7% 4
2024
Q4
$69.7M Buy
+90,326
New +$74.8M 0.86% 24

Other funds holding LLY

Castle Hook Partners's LLY Position: Q2 2026 in Review

Castle Hook Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 465,187 shares worth $558M. The stake represents 2.56% of the portfolio and ranks #4 among its holdings. This is a return to the name: Castle Hook Partners previously reported a position in LLY as recently as Q4 2025.

Castle Hook Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Castle Hook Partners held 465,187 shares of Eli Lilly worth $558M as of Q2 2026.
  • Eli Lilly was a new Castle Hook Partners position in Q2 2026.
  • Eli Lilly made up 2.56% of Castle Hook Partners's portfolio in Q2 2026, its #4 holding.
  • Castle Hook Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Castle Hook Partners's 13F filing for Q2 2026, filed 14 Aug 2026.